<DOC>
	<DOCNO>NCT01428986</DOCNO>
	<brief_summary>This study investigate safety maraviroc examine whether bone metabolism dysfunction actual use maraviroc human body , , measure bone mineral density marker bone formation , desorption chemokine .</brief_summary>
	<brief_title>Safety Study Maraviroc 's Effect Human Osteoclasts</brief_title>
	<detailed_description>An observational study investigate safety maraviroc examine whether bone metabolism dysfunction actual use maraviroc human body , , measure bone mineral density marker bone formation , desorption chemokine .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Maraviroc</mesh_term>
	<criteria>Outpatients inpatient treat HIV infection AIDS Clinical Center National Center Global Health Medicine meet criterion follow : Those whose primary care physician acknowledge necessity maraviroc treatment due multiresistance HIV strain confirm CCR5 tropism . Those willing able consent study 20 year old old Cases applicable ANY condition following : Those suit maraviroc ( whose HIV strain CXCR4 tropism ) Others principle investigator physician consider exclude</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>maraviroc</keyword>
	<keyword>osteoclast</keyword>
	<keyword>Receptors , CCR5</keyword>
	<keyword>Chemokine CCL5</keyword>
</DOC>